World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
76
Citations
24183
World Ranking
1401
National Ranking
40

Medicine

D-Index
78
Citations
25362
World Ranking
17944
National Ranking
597

Monica A. Slavin publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Monica A. Slavin sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 381 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Monica A. Slavin D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Monica A. Slavin sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Monica A. Slavin is affiliated with the Peter MacCallum Cancer Centre in Australia, with a focus on medicine and infectious diseases in oncology. Their primary research areas encompass epidemiology, infectious diseases, and oncology, with significant contributions to clinical biochemistry and pharmacology.

Their recent research includes studies published in prominent journals such as The Lancet Infectious Diseases, Clinical Infectious Diseases, The Medical Journal of Australia, and The Lancet Oncology. Notable papers include:

  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology (2021, The Lancet Infectious Diseases)
  • The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study (2020, Clinical Infectious Diseases)
  • Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance (2020, The Medical Journal of Australia)
  • 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation (2021, The Lancet Oncology)
  • Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum (2024, Clinical Infectious Diseases)

Monica A. Slavin has collaborated frequently with a range of researchers, including:

  • Karin Thursky (60 joint publications)
  • Benjamin W. Teh (51 joint publications)
  • Michelle K. Yong (35 joint publications)
  • Gabrielle M. Haeusler (27 joint publications)
  • Leon J. Worth (26 joint publications)

Their works are commonly published in leading infectious disease and antimicrobial journals, with multiple publications appearing in:

  • Transplant Infectious Disease (24 publications)
  • Open Forum Infectious Diseases (15 publications)
  • Journal of Antimicrobial Chemotherapy (11 publications)
  • Clinical Infectious Diseases (9 publications)
  • Internal Medicine Journal (9 publications)

Main topics covered in their research include:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Neutropenia and cancer infections
  • Cytomegalovirus and herpesvirus research
  • Bacterial identification and susceptibility testing
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Infectious diseases and mycology

Best Publications

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Oliver A. Cornely;Ana Alastruey-Izquierdo;Dorothee Arenz;Sharon C. A. Chen

  • Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation—A Prospective, Randomized, Double-Blind Study

    M A Slavin;B Osborne;R Adams;M J Levenstein

  • The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.

    W. Jeong;C. Keighley;C. Keighley;R. Wolfe;W.L. Lee

  • Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.

    Kieren A. Marr;Kristy Seidel;Monica A. Slavin;Raleigh A. Bowden

  • Combination antifungal therapy for invasive aspergillosis a randomized trial

    Kieren A. Marr;Haran T. Schlamm;Raoul Herbrecht;Scott T. Rottinghaus

  • Echinocandin antifungal drugs in fungal infections: a comparison

    Sharon C. A. Chen;Monica A. Slavin;Tania C. Sorrell

  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

    Martin Hoenigl;Jon Salmanton-García;Thomas J. Walsh;Thomas J. Walsh;Marcio Nucci

  • European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia

    J.A. Maertens;C. Girmenia;R.J.M. Bruggemann;R.F. Duarte

  • Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients

    Peter Troke;Koldo Aguirrebengoa;Carmen Arteaga;David Ellis

  • Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

    Orla Morrissey;Orla Morrissey;Sharon C-A Chen;Sharon C-A Chen;Sharon C-A Chen;Tania Christine Sorrell;Tania Christine Sorrell;Tania Christine Sorrell;Sam Milliken

  • Toxoplasma gondii infection in marrow transplant recipients : a 20 year experience

    M A Slavin;J D Meyers;J S Remington;R C Hackman

  • Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.

    Christopher C. Blyth;Sharon C. A. Chen;Monica A. Slavin;Carol Serena

  • Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

    B. P. Howden;M. A. Slavin;A. P. Schwarer;A. M. Mijch

  • Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

    Karin A Thursky;Leon J Worth;Leon J Worth;John F Seymour;H Miles Prince;H Miles Prince

  • Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death

    Sharon C A Chen;Sharon C A Chen;Sharon C A Chen;Monica Slavin;Christopher Heath;Geoffrey Playford

  • Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.

    E Geoffrey Playford;Deborah Marriott;Quoc Nguyen;Sharon Chen

  • Active surveillance for candidemia, Australia.

    Sharon Chen;Monica Slavin;Quoc Nguyen;Deborah Marriott

  • Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.

    P. Lewis White;John R. Wingard;Stéphane Bretagne;Jürgen Löffler

  • ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.

    Cesaro S;Dalianis T;Hanssen Rinaldo C;Koskenvuo M

  • Combination Antifungal Therapy for Invasive Aspergillosis

    Kieren A. Marr;Haran T. Schlamm;Raoul Herbrecht;Scott T. Rottinghaus

Frequent Co-Authors

Sharon C.-A. Chen
Sharon C.-A. Chen Westmead Hospital
Tania C. Sorrell
Tania C. Sorrell University of Sydney
John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre
David Ritchie
David Ritchie Peter MacCallum Cancer Centre
Jeff Szer
Jeff Szer Peter MacCallum Cancer Centre
Deborah Marriott
Deborah Marriott Ascension Health
Andrew Grigg
Andrew Grigg Austin Hospital
Elizabeth J. Phillips
Elizabeth J. Phillips Vanderbilt University Medical Center
Catriona Halliday
Catriona Halliday Westmead Hospital
Sarah Kidd
Sarah Kidd South Australia Pathology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens a variety of career options, many of which intersect with healthcare and data management fields. Beyond laboratory research, professionals can explore roles in health information systems or advanced clinical practice.

For those interested in advancing clinical expertise, becoming a functional nurse practitioner offers a compelling pathway. This role integrates patient care with a focus on holistic treatment approaches, often requiring specialized training beyond a microbiology background.

Alternatively, the healthcare industry has a strong demand for roles like Certified Professional Coders. Understanding medical billing and coding is essential for managing patient information accurately. Exploring the cpc medical coding salary and career paths can provide insight into this field’s financial and growth prospects.

For those interested in data and administrative roles, a bachelor of science in health information management salary reveals competitive compensation for managing healthcare data systems. Online programs, including the best online health information management degree cahiim accredited, provide convenient options to develop expertise in this growing field while pursuing microbiology studies.

Best Scientists Citing Monica A. Slavin

Trending Scientists

Recently Published Articles